India’s IPO pipeline stays active heading into year-end, led by Gujarat Kidney and Super Speciality’s Rs 251-crore mainboard issue opening December 22. Alongside it, nearly 10 SME IPOs aim to raise about Rs 420 crore, keeping the primary market busy despite muted grey market premiums.
​India’s IPO pipeline stays active heading into year-end, led by Gujarat Kidney and Super Speciality’s Rs 251-crore mainboard issue opening December 22. Alongside it, nearly 10 SME IPOs aim to raise about Rs 420 crore, keeping the primary market busy despite muted grey market premiums. by Soban News (international And National News)
